InFlectis BioScience
Latest round
- Series A
Last raised
- Jan 2017
Total raised
- $6.2M
Investors
- 5
About InFlectis BioScience
Founded in 2013 and headquartered in Nantes, France, InFlectis BioScience specializes in the development of therapies for neurological conditions. The company was co-founded by Philippe Guédat, who has a history of entrepreneurship in the biotech sector.InFlectis BioScience develops therapeutics aimed at addressing protein misfolding diseases, especially neurological disorders such as Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), and Multiple Sclerosis (MS). The company focuses on multifunctional, brain-penetrant small molecules that target various mechanisms involved in these conditions to mitigate disease progression and enhance patient outcomes.60 for the same year. The company is looking to expand into additional geographic markets, specifically targeting regions in Europe and North America by 2025.
Who invested in InFlectis BioScience
5 investors across 2 rounds
See all investors in InFlectis BioScience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about InFlectis BioScience
Who invested in InFlectis BioScience?
InFlectis BioScience has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InFlectis BioScience raised?
InFlectis BioScience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did InFlectis BioScience last raise money?
InFlectis BioScience's most recent round on record is a Series A, in Jan 2017.
What does InFlectis BioScience do?
Founded in 2013 and headquartered in Nantes, France, InFlectis BioScience specializes in the development of therapies for neurological conditions.
Where is InFlectis BioScience headquartered?
InFlectis BioScience is headquartered in Nantes, France.
Which VCs invest in companies like InFlectis BioScience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at InFlectis BioScience's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like InFlectis BioScience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.